JP2008524183A5 - - Google Patents

Download PDF

Info

Publication number
JP2008524183A5
JP2008524183A5 JP2007546172A JP2007546172A JP2008524183A5 JP 2008524183 A5 JP2008524183 A5 JP 2008524183A5 JP 2007546172 A JP2007546172 A JP 2007546172A JP 2007546172 A JP2007546172 A JP 2007546172A JP 2008524183 A5 JP2008524183 A5 JP 2008524183A5
Authority
JP
Japan
Prior art keywords
peaks
difumarate
azd0530 difumarate
azd0530
scale
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007546172A
Other languages
English (en)
Japanese (ja)
Other versions
JP5161584B2 (ja
JP2008524183A (ja
Filing date
Publication date
Priority claimed from GBGB0427697.8A external-priority patent/GB0427697D0/en
Application filed filed Critical
Publication of JP2008524183A publication Critical patent/JP2008524183A/ja
Publication of JP2008524183A5 publication Critical patent/JP2008524183A5/ja
Application granted granted Critical
Publication of JP5161584B2 publication Critical patent/JP5161584B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007546172A 2004-12-17 2005-12-14 化学的方法 Expired - Lifetime JP5161584B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0427697.8 2004-12-17
GBGB0427697.8A GB0427697D0 (en) 2004-12-17 2004-12-17 Chemical process
PCT/GB2005/004807 WO2006064217A2 (en) 2004-12-17 2005-12-14 PROCESS FOR THE PREPARATION OF 4-(6-CHLORO-2, 3-METHYLENEDIOXYANILINO)-7-[2-(4-METHYLPIPERAZIN-l-YL) ETHOXY]-5-TETRAHYDROPYRAN-4-YLOXYQUINAZOLINE , THEIR INTERMEDIATES AND CRYSTALLINE SALTS THEREOF

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008318186A Division JP2009143920A (ja) 2004-12-17 2008-12-15 化学的方法

Publications (3)

Publication Number Publication Date
JP2008524183A JP2008524183A (ja) 2008-07-10
JP2008524183A5 true JP2008524183A5 (https=) 2009-02-19
JP5161584B2 JP5161584B2 (ja) 2013-03-13

Family

ID=34090249

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007546172A Expired - Lifetime JP5161584B2 (ja) 2004-12-17 2005-12-14 化学的方法
JP2008318186A Pending JP2009143920A (ja) 2004-12-17 2008-12-15 化学的方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008318186A Pending JP2009143920A (ja) 2004-12-17 2008-12-15 化学的方法

Country Status (16)

Country Link
US (1) US8304417B2 (https=)
EP (1) EP1871769B1 (https=)
JP (2) JP5161584B2 (https=)
KR (6) KR20080094847A (https=)
CN (1) CN101115744B (https=)
AU (2) AU2005315458B2 (https=)
BR (1) BRPI0519085A2 (https=)
CA (2) CA2590735C (https=)
ES (1) ES2622480T3 (https=)
GB (1) GB0427697D0 (https=)
IL (1) IL183525A0 (https=)
MX (1) MX2007007210A (https=)
NO (1) NO20072755L (https=)
NZ (1) NZ555468A (https=)
WO (1) WO2006064217A2 (https=)
ZA (1) ZA200704532B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0412074D0 (en) * 2004-05-29 2004-06-30 Astrazeneca Ab Combination product
WO2009068906A2 (en) * 2007-11-26 2009-06-04 Astrazeneca Ab Combinations comprising zd4054 and a src family kinase inhibitor 172
CN103275072B (zh) * 2013-05-22 2016-01-20 苏州明锐医药科技有限公司 塞卡替尼的制备方法
US11241434B2 (en) 2013-06-13 2022-02-08 Yale Uninversity Compositions and methods for improving cognition in a subject
US10660957B2 (en) * 2013-06-13 2020-05-26 Yale University Compositions and methods for treating an Aβ-modulated disease or disorder or improving cognition in a subject
US10369152B2 (en) 2015-02-13 2019-08-06 The Brigham And Women's Hospital, Inc. Methods and compositions for the treatment or prevention of abnormal bone formation in a soft tissue
PT3930715T (pt) 2019-02-27 2024-08-02 Astrazeneca Ab Saracatinib para uso no tratamento de fibrose pulmonar idiopática
CN116332789A (zh) * 2023-03-10 2023-06-27 上海康鹏科技股份有限公司 一种4-氨基-2-氟苯甲酰胺的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA73993C2 (uk) * 2000-06-06 2005-10-17 Астразенека Аб Хіназолінові похідні для лікування пухлин та фармацевтична композиція
CA2419301C (en) 2000-08-21 2009-12-08 Astrazeneca Ab Quinazoline derivatives
DE60229046D1 (de) 2001-04-19 2008-11-06 Astrazeneca Ab Chinazolin derivate
RU2350618C2 (ru) 2002-11-04 2009-03-27 Астразенека Аб ПРОИЗВОДНЫЕ ХИНАЗОЛИНА В КАЧЕСТВЕ ИНГИБИТОРОВ Src ТИРОЗИНКИНАЗЫ
GB0226434D0 (en) 2002-11-13 2002-12-18 Astrazeneca Ab Combination product
GB0307333D0 (en) 2003-03-29 2003-05-07 Astrazeneca Ab Therapeutic agent
GB0309850D0 (en) 2003-04-30 2003-06-04 Astrazeneca Ab Quinazoline derivatives
GB0310401D0 (en) * 2003-05-07 2003-06-11 Astrazeneca Ab Therapeutic agent

Similar Documents

Publication Publication Date Title
WO2008091670A3 (en) Organic semiconductor materials and precursors thereof
RU2007110026A (ru) ПОЛИМОРФНЫЕ И АМОРФНАЯ ФОРМЫ ФОСФАТНОЙ СОЛИ 8-ФТОР-2-{4-[(МЕТИЛАМИНО)МЕТИЛ]ФЕНИЛ}-1,3,4,5-ТЕТРАГИДРО-6Н-АЗЕПИНО[5.4.3-cd]ИНДОЛ-6-ОНА
JP2010501478A5 (https=)
JP2007145875A5 (https=)
JP2007532560A5 (https=)
JP2010504343A5 (https=)
JP2010509775A5 (https=)
JP2008525416A5 (https=)
JP2006514626A5 (https=)
CA2537092A1 (en) Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
JP2006519818A5 (https=)
TNSN07164A1 (en) Quinuclidine derivatives and their use as muscarinic m3 receptor antagonists
CO6410293A2 (es) Nueva formula cristalina vi de la agomelatina preparación y uso de la misma
JP2010526814A5 (https=)
JP2008518904A5 (https=)
WO2008126732A1 (ja) 縮合二環式ヘテロアリール誘導体
MX2010003001A (es) Derivados de quinolina como antagonistas del receptor de la 5-hidroxitriptamina 5a.
WO2007147771A3 (en) Tetralin and indane derivatives and uses thereof
WO2006100635A3 (en) Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists
JP2008524183A5 (https=)
JP2012502111A5 (https=)
ATE374190T1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
WO2009080721A3 (en) 4 -aminopyrimidine derivatives as histamine h4 receptor antagonists
RS52663B2 (sr) Nova kristalna forma tiotropijum bromida i proces njene pripreme
JP2011500575A5 (https=)